In-Depth Report Covers Asia Pacific Markets for INR Transcatheter Embolization &...

In-Depth Report Covers Asia Pacific Markets for INR Transcatheter Embolization & Occlusion Devices

DUBLIN, Ireland--(Business Wire)--
Research and Markets
(http://www.researchandmarkets.com/reports/c82084) has announced the
addition of Asia Pacific Markets for INR Transcatheter Embolization &
Occlusion Devices to their offering.

In 2005, the Asia Pacific interventional neuroradiology (INR)
transcatheter embolization and occlusion (TEO) market was valued at
over $46 million.

The following report uses a number of methodologies to gather and
present data and analysis. At the outset, a large survey of secondary
sources is conducted. These sources act as the basis for the primary
research stage, which builds and enhances the quantitative and
qualitative attributes of the early research. Secondary sources
include:

Government Sources:

- Securities and Exchange Commission filings

- Food and Drug Administration and patent filings

- National Center for Health Statistics data

Transcatheter Embolization and Occlusion Companies:

- Annual reports, product brochures, corporate profiles, etc.

Internal Databases and Reports:

- Previous reports on similar/related sources

General Internet Searches, Medical Literature and
Newspaper/Magazine Searches:

- Identifying various centers of specialization and articles that
might provide leads for primary research.

The secondary research stage builds the foundation for the primary
research. The primary research methodology has four steps:

Step 1: The first step involves an impartial scan of all the
information gathered during the secondary research stage to determine
its utility based on the specific requirements of this report. Each
piece of information is, thus, either discarded or marked as high or
low priority. It is then organized appropriately as determined by the
structure and sectioning of the report.

Step 2: At this stage, early assumptions are formed as to the
implications of the information for the various transcatheter
embolization and occlusion market segments. These assumptions are then
used to determine hypotheses using both inductive and deductive
approaches. On the quantitative front, these hypotheses result in full
historical and projected market data sets (market sizes (units and
US$) and market shares).

Step 3: At this stage, the research is in position for it's most
important primary phase -- expert interviews. Throughout the secondary
research, industry and medical experts are identified. These experts
are now contacted by telephone and asked to participate in interviews
on recent trends and developments in the industry. Interviews are
either conducted at the time of the initial call or scheduled at the
convenience of the expert. Interview questions are tailored to the
expertise of the particular interviewee, although in most cases, the
most important questions are asked of all experts. The questions are
largely based on the assumptions and hypotheses developed in Step 2,
which are then either augmented, discarded, or adjusted, based on the
views and positions put forth. Attempts are made, whenever possible,
to cross-check the views of various experts against each other and
reach

positions of consensus on issues and market numbers.

Step 4: The final stage of primary research involves individual
and group analysis. All research results are assessed and
cross-checked thoroughly to determine their validity, relevance, and
weight. From this process, qualitative conclusions are reached and
data points finalized.

Forecast Methodology

In addition to Steps 1 through 4 (as outlined above), the
following "bottom-up" methodology was followed in developing forecast
assumptions for this report. A comprehensive breakdown of various
transcatheter embolization and occlusion procedures was prepared using
data from several sources including professional associations,
government statistics, and private research/media sources. Industry
experts and practitioners were consulted to ensure accuracy and verify
observed trends. As a cross-check, total industry revenues available
through 10Ks and other sources were compared against modeled industry
revenues.

Using the best estimates of industry experts, practitioners,
private research/media sources, and in-house experts, year-by-year
growth rates and average selling prices were applied individually to
each subcategory to derive forecasts. These estimates were
cross-checked by industry experts (marketing managers, product
managers, CEOs, etc.) and further refined. Overall findings were
compared against market and procedure forecasts published by other
sources to ensure reasonable estimates.

TABLE OF CONTENTS

LIST OF EXHIBITS

EXECUTIVE SUMMARY

METHODOLOGY

1.0 ASIA PACIFIC INR TEO MARKET .

1.1 Market Overview .

1.2 Asia Pacific Health Care Overview

1.2.1 Chinese Health Care and Reimbursement Overview

1.2.2 Australian Health Care and Reimbursement Overview

1.2.3 Indian Health Care and Reimbursement Overview

1.2.4 South Korean Health Care and Reimbursement Overview

1.2.5 Taiwanese Health Care Overview

1.2.6 Thai Health Care and Reimbursement Overview

1.2.7 Malaysian Health Care and Reimbursement Overview

1.2.8 Rest of Asia Pacific Health Care and Reimbursement Overview

1.3 Market Analysis

1.3.1 Procedures

1.3.2 Market Forecast

1.3.3 Market Drivers and Limiters

1.4 Competitive Analysis

2.0 INR EMBOLIZATION COIL MARKET

2.1 Market Overview

2.2 Market Analysis

2.2.1 Procedures

2.2.2 Procedures, by Country

2.2.2.1 China

2.2.2.2 India

2.2.2.3 Australia

2.2.2.4 South Korea

2.2.2.5 Thailand

2.2.2.6 Taiwan

2.2.2.7 Malaysia

2.2.3 Market Forecast

2.2.3.1 Bare Embolization Coils

2.2.3.2 Coated Embolization Coils

2.2.4 Market Drivers and Limiters

2.3 Competitive Analysis

3.0 ACCESSORY DEVICE MARKET

3.1 Market Overview

3.2 Market Analysis

3.2.1 Procedures

3.2.1.2 3.2.1.1 INR Guidewires

3.2.1.3 INR Guiding Catheters

3.2.1.4 INR Microcatheters

3.2.1.5 Temporary Occlusion Balloons

3.2.1.6 Coiling-Assist Stents

3.2.1.7 PV Microcatheters

3.2.2 Market Forecast

3.2.3 Market Drivers and Limiters

3.3 Competitive Analysis

4.0 ARTERIOVENOUS MALFORMATION TREATMENT MARKET

4.1 Market Overview

4.2 Market Analysis

4.2.1 Procedures

4.2.1.1 PVA Particles

4.2.1.2 Microspheres

4.2.1.3 Onyx Liquid Embolic

4.2.1.4 Embolic Glue

4.2.2 Market Forecast

4.2.3 Market Drivers and Limiters

4.3 Competitive Analysis

5.0ISCHEMIC STROKE TREATMENT MARKET

5.1 Market Overview

5.2 Market Analysis

5.2.1 Procedures

5.2.1.1 Stent Revascularization

5.2.1.2 Clot Retrieval

5.2.2 Market Forecast

5.2.3 Market Drivers and Limiters

5.3 Competitive Analysis

MRG ACRONYMS AND INITIALISMS stExh

EXECUTIVE SUMMARY

List of Exhibits

For more information visit
here

Source: Millennium Research Group

Research and Markets
Laura Wood, Senior Manager
Fax: +353 1 4100 980
press@researchandmarkets.com

Copyright Business Wire 2008